HARBOUR INVESTMENTS, INC.

Position in HLN — Haleon plc

CIK 810121 MADISON, WI

Position in HLN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$58,848

+$50,204 QoQ

Shares Held

5,879

+587.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOUR INVESTMENTS, INC. holds $1,485,705 across 37 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RMTI	Rockwell Medical, Inc.	33,674	$299,698
2	ZTS	Zoetis Inc.	2,164	$255,806
3	HIMS	Hims & Hers Health, Inc.	10,014	$207,890
4	TAK	Takeda Pharmaceutical Co Ltd	8,107	$150,141
5	VTRS	Viatris Inc	10,434	$140,963
6	HROW	Harrow, Inc.	1,970	$69,462
7	HLN	Haleon plc This page	5,879	$58,848
8	TEVA	Teva Pharmaceutical Industries Ltd	1,553	$46,776

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$58,848	5,879	+587.6%	Shares	Sole	2026-05-15
2025-12-31	$8,644	855	-1.8%	Shares	Sole	2026-02-09
2025-09-30	$7,812	871	+27.0%	Shares	Sole	2025-11-12
2025-06-30	$7,113	686	-89.7%	Shares	Sole	2025-07-28
2025-03-31	$68,284	6,636	-4.0%	Shares	Sole	2025-05-08
2024-12-31	$65,969	6,915	+4.2%	Shares	Sole	2025-02-10
2024-09-30	$70,208	6,636	0.0%	Shares	Sole	2024-11-04
2024-06-30	$54,813	6,636	-3.1%	Shares	Sole	2024-07-26
2024-03-31	$58,122	6,846	-12.8%	Shares	Sole	2024-07-22
2023-12-31	$64,589	7,848	+11.3%	Shares	Sole	2024-02-16
2023-09-30	$58,751	7,053	+11.3%	Shares	Sole	2023-11-15
2023-06-30	$53,087	6,335	-1.5%	Shares	Sole	2023-08-15
2023-03-31	$52,340	6,430	-3.6%	Shares	Sole	2023-05-15
2022-12-31	$53,368	6,671	—	Shares	Sole	2023-02-16
No filing history on record for this holder in this stock.